Building on this legacy, Grace has never rested on its laurels. In 2019, Grace FCMS completed a 9,000 sq. ft capacity expansion of our R&D facilities, creating vastly more space for our teams to work on our customer’s projects at lab scale and kilo lab. Our experience and state-of-the-art facilities and equipment will progress your drug substance faster and more efficiently than ever before, providing solutions to development challenges.
Tightly integrated teams
Grace FCMS R&D and analytical teams at South Haven, Michigan and Tyrone, Pennsylvania are able to work together easily, and bring diverse collective knowledge across regulatory starting materials (RSMs), intermediates and active pharmaceutical ingredients (APIs).